PP_1170x120_10-25-21

ZipDose

Spritam is first FDA-approved 3D printed drug

Spritam is first FDA-approved 3D printed drug

BLUE ASH, Ohio — Aprecia Pharmaceuticals Co. has received Food and Drug Administration approval for Spritam levetiracetam for oral use, an epilepsy treatment made using three-dimensional printing (3DP) technology. The company said Monday that the medication is the first drug product manufactured with 3DP technology that has been approved by the FDA. Spritam uses Aprecia’s